From: Haematogenous Staphylococcus aureus meningitis. A 10-year nationwide study of 96 consecutive cases
Chraracteristics | All Patients (N = 96) | Survivors (N = 42) | Non-survivors (N = 54) | P value |
---|---|---|---|---|
Age, yr | 67 (0–97) | 54 (0–97) | 72 (35–90) | <0.001 |
Male/female gender, No | 42/54 | 20/21 | 22/33 | = 0.50 |
Cell count, total | 149 (1–13870) | 105 (2–2410) | 196 (1–13870) | = 0.097 |
Cell count, %polymorphnuclear | 90 (40–100) (N = 46) | 86 (40–100) (N = 19) | 90 (50–100) (N = 27) | = 0.47 |
S-glucose, mmol/l | 7.6 (5–35) (N = 36) | 6.9 (5–11) (N = 15) | 8.4 (6–35) (N = 21) | = 0.048 |
CRP, mg/l | 245 (25–459) (N = 32) | 258 (25–392) (N = 15) | 222 (138–459) (N = 17) | = 0.48 |
Initial treatment, No | ||||
Relevant | 34 | 16 | 18 | |
Irrelevant | 53 | 20 | 33 | = 0.27 |
Pitt score≥4, No | 56 | 16 | 40 | = 0.006 |
Other secundary focus, No | 57 | 28 | 29 | = 0.35 |
Intra-veneous drug use, No | 12 | 9 | 3 | = 0.028 |
Comorbidity, No | ||||
None | 26 | 5 | 21 | |
1 | 36 | 24 | 12 | |
>1 | 35 | 26 | 9 | <0.001 |